Concepedia

New linker structures applied in glycosite-specific antibody drug conjugates

FARIDOON FARIDOON, Wei Shi, Ken Qin, Yubo Tang, Mingjie Li, Dongliang Guan, Xiaobo Tian, Bofeng Jiang, Jinhua Dong, Feng Tang,

Organic Chemistry Frontiers · 2019 · 14 citations · 28 references

DOI

Concepts

Abstract

Two new linkers employed in glycosite-specific antibody–drug conjugates demonstrate efficient conjugation, enhanced stability, and fluorescence properties.

References

28

Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index

Jagath R. Junutula, Helga Raab, Suzanna Clark et al. · Nature Biotechnology · 2008 · 1.4K citations

, , +16

Development of potent monoclonal antibody auristatin conjugates for cancer therapy

Svetlana O. Doronina, Brian E. Toki, Michael Torgov et al. · Nature Biotechnology · 2003 · 1.2K citations

, , +14

The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma

Peter D. Senter, Eric L. Sievers · Nature Biotechnology · 2012 · 752 citations

, , +15

Synthesis of site-specific antibody-drug conjugates using unnatural amino acids

Jun Y. Axup, Krishna Bajjuri, Melissa Ritland et al. · Proceedings of the National Academy of Sciences · 2012 · 582 citations · Full text

, , +17

Recent advances in the construction of antibody–drug conjugates

Vijay Chudasama, Antoine Maruani, Stephen Caddick · Nature Chemistry · 2016 · 350 citations · Full text

, , +14